Connect with us

Health

Ava Announces Launch of First Clinical Trial Evaluating Effectiveness of Its Fertility Tracking Sensor Bracelet in Real-time, Pre-Symptomatic Detection of COVID-19 – PRNewswire

/PRNewswire/ — Ava, a digital healthcare company that focuses on women’s reproductive health, announced today it will be launching the first study of its kind……

Published

on

Article feature image

ZURICH, March 23, 2021 /PRNewswire/ — Ava, a digital healthcare company that focuses on women’s reproductive health, announced today it will be launching the first study of its kind to test whether a wearable device can detect a COVID-19 infection in real-time and alert people to get tested or self-isolate prior to showing symptoms.
While other studies to date (including the COVI-GAPP study Ava announced in April 2020
) have  examined the feasibility of using machine learning and wearable devices…

Click here to view the original article.

Continue Reading
Advertisement
Advertisement

Trending